Biotech stem cells could zero in on tumors, study says

05/19/2009 | Yahoo!

U.S. scientists have genetically engineered bone marrow-derived stem cells to produce and directly deliver a cancer-killing protein called TNF-related apoptosis-inducing ligand to tumors. Studies on mice and cell cultures showed that the cells proved effective in targeting various types of cells without causing harm to healthy tissues.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC